Verified Nov 2026
Batteries & E-Mobility
·

Cary, North Carolina
·
Since 1994
Allucent is a Contract Research Organization headquartered in Cary, North Carolina, founded in 1994 and employing 1,000–5,000 people. The company partners with small and mid-sized biopharmaceutical firms to advance therapies through clinical development and regulatory pathways. It conducts clinical trials across oncology, neuroscience, infectious diseases, and rare diseases in over 60 countries. In 2026, Allucent launched its IGNITE site network to improve clinical trial speed and quality.
Allucent at a glance
Revenue
$100-250M
Est. band
Employees
1,000-5,000
Founded
1994
Headquarters
Cary, North Carolina
Industries
Automotive
Electric Vehicles
Medical
Overview
Allucent is a Contract Research Organization headquartered in Cary, North Carolina, founded in 1994 and employing 1,000–5,000 people. The company partners with small and mid-sized biopharmaceutical firms to advance therapies through clinical development and regulatory pathways. It conducts clinical trials across oncology, neuroscience, infectious diseases, and rare diseases in over 60 countries. In 2026, Allucent launched its IGNITE site network to improve clinical trial speed and quality.
At a glance
Attribute | Detail |
|---|---|
Founded | 1994 |
Headquarters | Cary, North Carolina |
Employees | 1,000-5,000 |
Revenue | $100-250M (estimated) |
Primary capability | Batteries & E-Mobility |
What Allucent makes
Allucent provides regulatory strategy, clinical operations, biometrics, clinical pharmacology, drug safety, biostatistics, and medical writing services tailored to early-stage therapies including cell and gene therapy.
Latest developments
2026-11-10 — Allucent Appoints Chief Medical Officer and Infectious Disease Therapeutic Strategy Head (prnewswire.com)
2026-06-30 — Allucent Launches IGNITE™ Site Network to Enhance Speed, Quality, and Predictability Across Clinical Trial Delivery (allucent.com)
2026-04-07 — Allucent Expands Strategic Leadership to Advance Centers of Expertise and Fortify Specialty CRO Position (allucent.com)
2026-03-30 — Quantum BioPharma Signs Binding Letter of Intent with Allucent to Conduct Phase 2 Clinical Trial in Multiple Sclerosis (allucent.com)
2026-01-07 — Silo Pharma Teams with Allucent for SPC-15 Trials (bioxconomy.com)
2025-12-30 — Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 - BioSpace (biospace.com)
Company details
The firm operates across North America, Europe, and the Middle East, with a specialized model designed to deliver high-touch partnerships for drug development in small and mid-sized biopharmaceutical organizations. Allucent was founded in 1994, has an estimated 1,000-5,000 employees, and is headquartered in Cary, North Carolina.
Frequently asked questions
What does Allucent make?
Allucent is a Contract Research Organization headquartered in Cary, North Carolina, founded in 1994 and employing 1,000–5,000 people. The company partners with small and mid-sized biopharmaceutical firms to advance therapies through clinical development and regulatory pathways. It conducts clinical trials across oncology, neuroscience, infectious diseases, and rare diseases in over 60 countries. In 2026, Allucent launched its IGNITE site network to improve clinical trial speed and quality.
Where is Allucent headquartered?
Allucent is headquartered in Cary, North Carolina (2000 Centregreen Way, Cary, North Carolina, 27513).
When was Allucent founded?
Allucent was founded in 1994.
How big is Allucent?
Allucent has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
